1991 U.S. Tax Ct. LEXIS 93">*93 Decision will be entered under Rule 155.
P is the related supplier of I, a domestic international sales corporation (DISC). P and I use the "50/50 combined taxable income" method of computing the transfer price allowable under
97 T.C. 457">*458 OPINION
Respondent determined the following deficiencies in petitioner's Federal income taxes:
Year | Deficiency |
1979 | $ 194,794 |
1981 | 233,956 |
1982 | 812,906 |
1983 | 832,559 |
After concessions, the deficiency determined for taxable year 1979 is no longer in 1991 U.S. Tax Ct. LEXIS 93">*95 issue. The issues remaining for decision with respect to taxable years 1981, 1982, and 1983 are:
(1) Whether the research and development expense allocation moratorium under section 223 of the Economic Recovery Tax Act of 1981 (section 223 of ERTA), Pub. L. 97-34, 95 Stat. 172, 249, is applicable to the computation of combined taxable income;
(2) whether research and development expenses attributable to medical devices which were never placed into production or offered for sale are allocable and apportionable as provided by
(3) whether
(a) to the extent it requires allocation of research and development expenses using Standard Industrial Classification (SIC) product categories for the computation of combined taxable income;
(b) to the extent it prohibits an allocation of research and development expenses using industry1991 U.S. Tax Ct. LEXIS 93">*96 and trade usage product categories;
(c) to the extent it precludes the use of the "wholesale trade category" in allocating research and development expenses; and
(d) to the extent it precludes the use of the "exclusive geographic apportionment method" in apportioning research and development expenses.
The parties submitted this case fully stipulated pursuant to Rule 122. 1 The stipulation of facts, supplemental stipulation of facts, and attached exhibits are incorporated herein.
Petitioner, a Minnesota corporation, had its principal place of business in St. Paul, Minnesota, when its petition was filed. Petitioner is an accrual basis, calendar year taxpayer which develops, manufactures, and sells medical products. Petitioner's only product during the years at issue was an artificial heart valve. Generally, in1991 U.S. Tax Ct. LEXIS 93">*97 the medical products business foreign sales precede domestic sales because of the time required to obtain Food and Drug Administration clearance to market medical products in the United States. Petitioner obtained clearance to market its heart valves in the United States on December 17, 1982.
On December 20, 1979, petitioner initiated a research and development project in order to produce a cardiac pacemaker. Due to escalating costs and startup problems, petitioner terminated its effort to develop the cardiac pacemaker in March of 1981. In April of 1980, petitioner 97 T.C. 457">*460 entered into a joint research and development project in order to produce an implantable insulin pump. Petitioner abandoned its effort to develop implantable insulin pumps in 1983. No sales of a cardiac pacemaker or insulin pump were ever attempted by petitioner or its subsidiaries. Cardiac pacemakers, insulin pumps, and heart valves constitute separate products or product lines under recognized industry or trade usage in the medical goods manufacturing industry.
On April 20, 1980, petitioner incorporated St. Jude International Sales Corporation (International), a wholly owned subsidiary, for the purpose of qualifying1991 U.S. Tax Ct. LEXIS 93">*98 it as a DISC and obtaining the tax deferral advantages available pursuant to the DISC provisions. International, an accrual basis taxpayer, operated on a January 31 fiscal year. Pursuant to a DISC commission agreement, petitioner was to pay International the maximum commission allowable under
Petitioner's total sales, domestic sales, export commission sales, and the percentage of export commission sales to total sales during calendar years 1981, 1982, and 1983 were:
Year | Total Sales | Domestic Sales | Export CommissionSales Involving International | % of Export Sales to Total Sales |
1981 | $ 13,206,395 | $ 4,953,507 | $ 8,252,888 | 62.48% |
1982 | 17,528,098 | 6,285,996 | 11,242,102 | 64.14% |
1983 | 25,624,428 | 11,847,468 | 13,776,960 | 53.76% |
During each year at issue, 100 percent of petitioner's research and development activity was performed in the United States. Because the terms of sale for International were1991 U.S. Tax Ct. LEXIS 93">*99 f.o.b., St. Paul, Minnesota, International bore the expense and risk of loss of putting a shipment into possession of the carrier.
A preliminary requirement in determining the tax deferral benefits available to petitioner through section 944(a)(2) of the DISC intercompany pricing rules is the computation of the "combined taxable income" of petitioner and International. 97 T.C. 457">*461 Combined taxable income equals the excess of the gross receipts of the DISC from export commission sales over the total costs of the DISC and its related supplier (petitioner) which relate to the gross receipts. In computing combined taxable income, petitioner failed to allocate any of the research and development expenses attributable to the cardiac pacemaker and the insulin pump to gross receipts from export sales. In addition, petitioner failed to allocate 30 percent of the research and development expenses attributable to the heart valve between gross receipts from export sales and all other gross receipts:
International Fiscal Year Ending | |||
Description | 1/31/82 | 1/31/83 | 1/31/84 |
Implantable insulin pump | $ 390,217 | -0- | -0- |
Implantable cardiac pacemaker | 390,121 | -0- | -0- |
30% exclusive apportionment | 87,719 | 451,123 | 552,200 |
Cost of terminating implantable insulin pump development | 655,806 | -0- | -0- |
Total | $ 1,523,863 | $ 451,123 | $ 552,200 |
1991 U.S. Tax Ct. LEXIS 93">*100 Respondent recomputed combined taxable income by allocating additional research and development expenses between gross receipts from export sales and all other gross receipts:
International Fiscal Year Ending | Additional Research and Development Expenses Allocated in Computing Combined Taxable Income |
1/31/82 | $ 1,523,863 |
1/31/83 | 451,123 |
1/31/84 | 552,200 |
The effect of respondent's determination is to reduce the combined taxable income of petitioner and International during the years in issue, which in turn reduces the amount of commissions deemed paid to International pursuant to
As part of the Revenue Act of 1971, Pub. L. 92-178, 85 Stat. 497, Congress enacted the DISC provisions (
A DISC is not liable for Federal income tax on its taxable income.
For an entity to qualify as a DISC, a variety of requirements under
(a) In General. -- In the case of a sale of export property to a DISC by a person described in 97 T.C. 457">*463 (1) 4 percent of the qualified export receipts on the sale of such property by the DISC plus 10 percent of the export promotion expenses of such DISC attributable to such receipts. (2) 50 percent of the combined taxable income of such DISC and such person which is attributable to the qualified export receipts on such property derived as the result of a sale by the DISC plus 10 percent of the export promotion expenses of such DISC attributable to such1991 U.S. Tax Ct. LEXIS 93">*103 receipts, or (3) taxable income based upon the sale price actually charged (but subject to the rules provided in
Petitioner determined its transfer price in accordance with
A DISC may operate on a "buy-sell" basis (by taking title to the property to be exported) or on a commission basis (under which it functions as a commission agent for export sales). (b) Rules for commissions, rentals, and marginal costing. -- The Secretary shall prescribe regulations1991 U.S. Tax Ct. LEXIS 93">*104 setting forth -- (1) rules which are consistent with the rules set forth in subsection (a) for the application of this section in the case of commissions, rentals, and other income * * *.
The term "combined taxable income," which appears in
97 T.C. 457">*464 the excess of the gross receipts (as defined in
* * *
(ii) Cost of goods sold shall be determined in accordance with the provisions of
(iii) Costs (other than costs of goods sold) which shall be treated as relating to gross1991 U.S. Tax Ct. LEXIS 93">*105 receipts from sales of export property are (a) the expenses, losses, and other deductions definitely related, and therefore allocated and apportioned, thereto, and (b) a ratable part of any other expenses, losses, or other deductions which are not definitely related to a class of gross income, determined in a manner consistent with the rules set forth in
Thus, in computing combined taxable income, costs relating to gross receipts are to be determined in a manner consistent with the rules of (2) * * * (ii) The maximum commission the1991 U.S. Tax Ct. LEXIS 93">*106 DISC may charge the related supplier is the sum of the amount of income determined under subdivision (i) of this subparagraph plus the DISC's total costs for the transaction as determined under paragraph (c)(6) of this section.
Operative sections require a computation of taxable income from a "statutory grouping" and a "residuary grouping." The term "statutory grouping" means the gross income from the specific source or activity which must first be determined in order to arrive at taxable income from such specific source or activity. Gross income from other sources or activities is referred to as the "residuary grouping."
A taxpayer must allocate deductions to the appropriate class of gross income and then, if necessary to make the determination required by the operative section, must apportion deductions within the class of gross income between the statutory grouping and the residual grouping.
However, some deductions are treated as "not definitely related to any gross income," and are ratably apportioned to all gross income.
Where a deduction has been allocated to a class of gross income which is included in both the statutory grouping and the residual grouping, the deduction must be apportioned between the statutory grouping and the residual grouping. If the class of gross income to which a deduction has been allocated is included in its entirety in either a single statutory grouping or the residual grouping, there is no need to1991 U.S. Tax Ct. LEXIS 93">*109 apportion that deduction.
A deduction is apportioned by attributing the deduction between gross income which is in the statutory grouping and gross income which is in the residual grouping. The attribution must be accomplished in a manner which reflects to a "reasonably close extent" the factual relationship between the deduction and the grouping of gross income.
97 T.C. 457">*467
Under
The final
Petitioner, and Intel Corporation (Intel) in its amicus curiae brief, argues that the research and development expense allocation moratorium provided by section 223 of ERTA permits the exclusion of 100 percent of research and development expenses from the combined taxable income computation. 3 Thus, petitioner and Intel contend none of petitioner's research and development expenses, including those attributable to heart valves, should be allocated to gross income from export sales.
1991 U.S. Tax Ct. LEXIS 93">*113 Section 223(a) of ERTA suspended the application of the allocation and apportionment rules under (a) 2-YEAR SUSPENSION -- In the case of the taxpayer's first 2 taxable years beginning within 2 years after the date of the enactment of the Act, all research and experimental expenditures (within the meaning of
Section 223(b) of ERTA directs the Treasury to conduct a study with respect to the impact which (b) STUDY -- (1) IN GENERAL. -- The Secretary of the Treasury shall conduct a study with respect to the impact which
The Treasury study called for by section 223 of ERTA was published in June of 1983. In the study the Secretary 97 T.C. 457">*469 reports that section 223 of ERTA did not reduce research and development allocations to combined taxable income. Department of the Treasury, The Impact of the Section 861-8 Regulation on U.S. Research and Development 17 n.7 (June 1983).
In enacting section 223 of ERTA, Congress focused its concern on the foreign tax credit impact of the geographic allocation of research expenses: A fundamental principle of the foreign tax credit is that it may not be used to offset the U.S. tax on U.S. source income. The foreign tax credit provisions contain a limitation that insures that the credit will not be used to offset the U.S. tax on U.S. source income. Under the limitation, a U.S. taxpayer is allowed a credit against its U.S. tax for foreign taxes paid on foreign source income only to the extent of the pre-credit U.S. tax on the foreign source income. [H. Rept. 97-201, at 130 (1981).] In determining foreign source taxable income for purposes of computing the foreign tax credit limitation,
The portion of the House report appearing under the heading "Reasons for Change" also focuses on the foreign tax credit limitation: Taxpayers that allocate research and development expenses for purposes of the foreign tax credit claim that the allocation results in more deductions being allocated overseas than is allowed as a deduction by the foreign country. Thus, taxpayers claim that their foreign tax credit limitation is lower than the foreign taxes paid and that they will lose foreign tax credits. Taxpayers argue that because of the application of the regulation, they must transfer research and development activities to the foreign country in order to get a deduction in that country and, thus, get a full foreign tax credit on the income earned1991 U.S. Tax Ct. LEXIS 93">*116 in that country. [H. Rept. 97-201,
Respondent contends that section 223 of ERTA is inapplicable to the computation of combined taxable income. In addition to the legislative history of section 223 of ERTA, 97 T.C. 457">*470 which focuses on the foreign tax credit, respondent relies on his analysis in
In
The computation of CTI (first stage) does not involve geographic sourcing of income. It requires apportionment of R&D expenses between the statutory grouping of gross income from exports and other gross income. The sourcing of the income as United States source or foreign source is irrelevant when allocating deductions for purposes of determining CTI. On the other hand, geographic sourcing of income is required for purposes of calculating the foreign tax credit limitation in the second stage of apportionment. [
Respondent then discusses the congressional purpose in enacting section 223 of ERTA:
The moratorium under section 223 of ERTA 81 was enacted because of Congressional concern that the allocation and apportionment of R&D expenses under
Respondent concludes that section 223 of ERTA is inapplicable to the computation of combined taxable income:
97 T.C. 457">*471 The determination of CTI differs from that of foreign source taxable income. CTI determines the relative amount of income earned by a DISC or FSC and its related supplier from the export of U.S. manufactured goods and, thereby, the tax benefit derived from the export transaction. A taxpayer may derive gross receipts qualifying for DISC or FSC treatment, calculate CTI, and claim the related tax benefits with respect to export transactions irrespective of whether they generate foreign source1991 U.S. Tax Ct. LEXIS 93">*119 or domestic source income. Therefore, the sourcing of income is not relevant for purposes of calculating CTI.
The moratorium enacted in section 223 of ERTA 81 and continued in section 126 of TRA 84 revised the allocation and apportionment of R&D expenses for identical reasons i.e., in order to modify the calculation of foreign source taxable income and adjust the foreign tax credit limitation. The moratorium was not intended to modify the amount of DISC or FSC benefits derived from export transactions and, therefore, does not apply to the determination of
A revenue ruling is not binding on this Court, since it only represents the contention of one party to a case.
Petitioner contends that respondent unreasonably narrows the scope of section 223 1991 U.S. Tax Ct. LEXIS 93">*120 of ERTA, citing the Conference Committee report accompanying ERTA, which in discussing the Senate amendment provides that, during the 2-year moratorium under section 223, research and development expenses attributable to research activities conducted in the United States are to be allocated and apportioned "to U.S. source income for all purposes under the Code." H. Rept. 97-215 (1981),
We find that the statement which petitioner cites is in keeping with respondent's interpretation of section 223 of ERTA. The moratorium was intended to apply for all purposes for which geographic sourcing is relevant. Because geographic sourcing of income is not an element in the computation of combined taxable income, the moratorium is inapplicable to a DISC.
The moratorium established by section 223 of ERTA was extended for another 2 years by section 126 of the Deficit 97 T.C. 457">*472 Reduction Act of 1984 (section 126 of DEFRA), Pub. L. 98-369, 98 Stat. 494, 648. Petitioner argues that the legislative history of section 126 of DEFRA demonstrates Congress' intent to narrow the broad original research and development expense allocation moratorium, which was applicable to the1991 U.S. Tax Ct. LEXIS 93">*121 computation of combined taxable income, to one that applied only to the computation of the foreign tax credit limitation. There would have been no need for Congress to amend the moratorium in 1984, petitioner argues, if section 223 of ERTA did not apply to a DISC.
However, section 126 of DEFRA was an extension of section 223 of ERTA, not an amendment. While the DEFRA conference report refers to a "clarification" of the Senate bill's effective date, it does not treat section 126 of DEFRA as other than an extension of the original moratorium. The conference report states:
* * *
The Senate amendment effectively extends for two years
The conference agreement follows the Senate amendment with a clarification of the effective date provision. The conference agreement provides that
The
Significantly, the conference report refers to section 223 of ERTA as "the moratorium," while it refers to section 126 of DEFRA as "the extension of the moratorium." The Conference Committee's terminology indicates that: (1) It considered section 126 of DEFRA as an extension of section 223 of ERTA, not an amendment, and (2) section 223 of 97 T.C. 457">*473 ERTA (the moratorium) was inapplicable to the computation of combined taxable income because it applied only for purposes of geographic sourcing of income, which is not an element of the computation. 1991 U.S. Tax Ct. LEXIS 93">*123 The conference report provides substantial support for respondent's analysis.
Section 13211 of the Consolidated Omnibus Budget Reconciliation Act of 1985, Pub. L. No. 99-272, 100 Stat. 82, 324, extended the moratorium for 1 year. Other than the effective dates of the moratorium, section 13211 made no changes.
Section 1216 of the Tax Reform Act of 1986, Pub. L. 99-514, 100 Stat. 2085, 2549, provided that for purposes of
The House Ways and Means Committee report discusses its view that the moratorium established by section 223 of ERTA should not be renewed: As a matter of tax policy, the committee is of the view that it is appropriate to require the allocation of deductible expenses (including research expenses) between U.S. and foreign source income. * * * Accordingly, the committee has decided 1991 U.S. Tax Ct. LEXIS 93">*124 not to renew the expired moratorium on the application of the * * * While the committee and Congress study these issues further (for a two-year period), the bill provides temporary rules for allocation of research expense that are based on the approach of the Treasury regulation, but that liberalize the Treasury regulation in certain respects. * * * The temporary modifications do not reflect a judgment by the committee that any provision of the existing Treasury research expense allocation rules is necessarily inadequate or inappropriate. [4] * * * 1991 U.S. Tax Ct. LEXIS 93">*125 97 T.C. 457">*474 The modifications apply only to the allocation of research and experimental expenditures for the purposes of geographic sourcing of income. They do not apply for other purposes, such as the computation of combined taxable income of a FSC (or DISC) and its related supplier. [H. Rept. 99-426 (1985),
Section 4009 of the Technical and Miscellaneous Revenue Act of 1988, Pub. L. 100-647, 102 Stat. 3342, 3653, provided that, for purposes of
Section 11401 of the Omnibus Budget Reconciliation Act of 1990, Pub. L. 101-508, 104 Stat. 1388, 1388-472, extended the application of the statutory allocation rule to apply to the first 2 taxable years beginning after August 1, 1989, and on or before August 1, 1991.
Petitioner has failed to introduce any contemporaneous legislative history indicating that Congress intended section 223 of ERTA to apply to the computation of combined taxable income. In addition, the legislative history of subsequent extensions of the moratorium indicates that section 223 of ERTA was inapplicable to the computation. We therefore 1991 U.S. Tax Ct. LEXIS 93">*127 reject petitioner's argument that, due to section 223 of ERTA, research and development expenses do not enter into the computation of combined taxable income.
Intel, in its brief filed as amicus curiae, misinterprets respondent's position regarding the effect of not applying 97 T.C. 457">*475 section 223 of ERTA in computing combined taxable income. Respondent, Intel argues, is incorrect in his assertion that the amount of petitioner's foreign source income is not affected by the nonapplication of section 223 of ERTA in determining combined taxable income. However, respondent agrees that section 223 of ERTA will ultimately affect the amount of petitioner's foreign source income. Respondent's position is that
Intel argues that respondent's inclusion of research and development expenses in the combined taxable income computation 7results in the allocation of the expenses to foreign source income in direct contravention of section 223 of ERTA. A DISC is allowed to earn a commission equal to 50 percent of the combined taxable income of the DISC and its related1991 U.S. Tax Ct. LEXIS 93">*128 supplier.
The allocation of research and development expenses between gross export sales and other gross income reduces combined taxable income, which in turn reduces the deemed distribution to the shareholder. Because the deemed distribution is classified as foreign source income, the initial inclusion of research and development expenses in the combined taxable income computation ultimately reduces the foreign source income of the shareholder attributable to DISC distributions.
Generally, foreign income taxes paid by a U.S.1991 U.S. Tax Ct. LEXIS 93">*129 taxpayer in connection with foreign source income qualify for credit against Federal income tax under section 901. In addition, foreign taxes "deemed paid" qualify for the foreign tax credit under section 902, which applies where dividends are received by a U.S. corporation from a foreign subsidiary. In these situations, allocations of research and development 97 T.C. 457">*476 expenditures under
Intel provides an example of the reduction of foreign source income due to the inclusion of research and development expenses in the combined taxable income computation: Shareholder and DISC have $ 100 of combined taxable income (assuming research and development1991 U.S. Tax Ct. LEXIS 93">*130 are not included in the computation) and research and development expenses totalling $ 20. The amount of shareholder's foreign source income resulting from deemed DISC distributions (assuming there are no additional deemed distributions pursuant to combined taxable income $ 100 X 50 percent DISC commission $ 50 X 57.5 percent deemed distribution (foreign source income) $ 28.75
If the $ 20 of research and development expenses are included in the combined taxable income computation and allocated as provided in
combined taxable income | $ 80 |
X 50 percent | |
DISC commission | $ 40 |
X 57.5 percent | |
deemed distribution (foreign source income) | $ 23 |
However, Intel fails to take into account that the portion of the1991 U.S. Tax Ct. LEXIS 93">*131 $ 20 in research and development expense which would otherwise be apportioned against the deemed distribution 97 T.C. 457">*477 for foreign tax credit purposes will be apportioned instead to U.S. source income because of section 223 of ERTA. Thus, under its interpretation of section 223 of ERTA, Intel would benefit both from the application of the moratorium to avoid allocating any research and development expenses in the combined taxable income computation, and the application of the moratorium to avoid apportioning research expenses to the deemed distribution, which is classified as foreign source income. Nothing in section 223 of ERTA or its legislative history, or the legislative history of subsequent extensions, supports such an interpretation.
Intel next argues, as does petitioner, that the legislative history of section 223 of ERTA indicates that the section applies for all purposes of the Internal Revenue Code, and specifically for purposes of computing combined taxable income. As we have already rejected this argument, we need not address it again. Finally, we have considered Intel's remaining arguments regarding the legislative history of section 126 of DEFRA and find them repetitive1991 U.S. Tax Ct. LEXIS 93">*132 and without merit. We therefore agree with respondent's determination that section 223 of ERTA is inapplicable to the computation of the combined taxable income of a DISC.
Petitioner argues that its failure to allocate research and development expenses attributable to the insulin pump and cardiac pacemaker between gross income from export sales and all other gross income in computing combined taxable income is proper because: (1)
Petitioner contends that only the research and development expenses attributable to heart valves enter into the 97 T.C. 457">*478 combined taxable income computation because the expenses1991 U.S. Tax Ct. LEXIS 93">*133 attributable to cardiac pacemakers and insulin pumps, which produced no export sales, are not "definitely related" to gross receipts resulting from export sales. We reject petitioner's argument because the relevant regulations provide otherwise.
A requirement that an expense be "definitely related" to gross income from export receipts in order to be allocated to the item does not exist in the text of the combined taxable income of a DISC and its related supplier from a sale of export property is the excess of the gross receipts (as defined in * * * (iii) Costs (other than cost of goods sold) which shall be treated as relating to
Both costs that are "definitely related" to gross receipts from the sales of export property and costs that are "not definitely related" to a class of gross income, determined consistently with
General provisions of law, petitioner argues, must yield to specific ones. (iv) The taxpayer's choice in accordance with subparagraph (7) of this paragraph as to the grouping of transactions shall be controlling, and costs deductible in a taxable year shall be allocated and apportioned to the items or classes of gross income of such taxable year resulting from such grouping. (7) Grouping Transactions. (i) Generally, the determinations under this section are to be made on a transaction-by-transaction basis. However, at the annual choice of1991 U.S. Tax Ct. LEXIS 93">*136 the taxpayer some or all of these determinations may be made on the basis of groups consisting of products or product lines. (ii) A determination by a taxpayer as to a product or a product line will be accepted by a district director if such determination conforms to any one of the following standards: (a) a recognized industry or trade usage, or (b) the two-digit major groups (or any inferior classifications or combinations thereof, within a major group) of the Standard Industrial Classification as prepared by the Statistical Policy Division of the Office of Management and Budget, Executive Office of the President. (iii) A choice by the taxpayer to group transactions for a taxable year on a product or product line basis shall apply to all transactions with respect to that product or product line consummated during the taxable year. However, the choice of a product or product line grouping applies only to transactions covered by the grouping and, as to transactions not encompassed by the grouping, the determinations are made on a transaction-by-transaction basis. For example, the taxpayer may choose a product grouping with respect to one product and use the transaction-by-transaction1991 U.S. Tax Ct. LEXIS 93">*137 method for another product within the same taxable year.
Petitioner misinterprets the purpose and application of the grouping provisions. The grouping provisions do not supersede the
Thus, had petitioner sold insulin pumps and cardiac pacemakers through International in addition to heart valves, pursuant to
97 T.C. 457">*481
The policy behind
However, petitioner argues, benefits of unsuccessful research into insulin dispensing devices or cardiac pacemakers are unlikely to result in unintended application in developing heart valve technology because they are unrelated and dissimilar products. Both research projects were discontinued, petitioner contends, with no benefit derived for heart value production.
Respondent replies that it may be impossible to determine whether research and development in one area may benefit product development in another. If the research and development expense allocation regulations provided for narrow product groupings, respondent argues, such expenses might not be properly allocated to the potentially wide category of products which may be developed due to the research efforts.
Petitioner has failed to establish that the relevant regulations do not comport with the "economic1991 U.S. Tax Ct. LEXIS 93">*140 reality" on which petitioner relies. In addition, respondent's purpose in promulgating and enforcing the relevant regulations is not to implement "economic reality," but rather to implement the congressional mandate in enacting the corresponding statutory provision. Petitioner has failed to indicate any authority, and we have found none, which would allow a taxpayer to disregard the Commissioner's interpretation of a Treasury regulation on the ground that the taxpayer's interpretation better matches "economic reality." We reject petitioner's argument because it lacks legal authority and is irrelevant to the issues to be decided.
The starting point in analyzing a regulation's validity is to define the Secretary's source of authority.
Petitioner argues that the Secretary's source of authority for promulgating
In In determining whether a particular regulation carries out the congressional mandate1991 U.S. Tax Ct. LEXIS 93">*142 in a proper manner,
97 T.C. 457">*483 If a regulation does not contradict or limit the plain language of the statute it interprets, or if the statutory language is so general as to render an interpretative regulation appropriate, it is valid if consistent with the statute's origin and purpose.
Petitioner argues that the general approach of
The inflexibility of the SIC product categories, argues petitioner, produces anomalous and unexpected results unintended by Congress, such as that of
Petitioner contends that, as in example 4, there is 1991 U.S. Tax Ct. LEXIS 93">*145 no factual relationship between (1) research and development expenses attributable to cardiac pacemakers and insulin pumps, and (2) research and development expenses attributable to heart valves.
Respondent argues that the legislative history of the DISC provisions establishes that Congress intended for combined taxable income to be computed in accordance with Under the second pricing rule provided by the bill, a DISC may earn up to 50 percent of the combined taxable income of the DISC and the related person arising from the sale of the property, plus an additional amount equal to 10 percent of the DISC's export promotion expenses attributable to the sale. For this rule,
While the House and Senate reports do state that combined taxable income is to be determined in accordance with the principles under
Not until 1977 were the current regulations issued, for the first time requiring that research and development expenses be allocated in accordance with SIC product categories. Therefore, the reference in the House and Senate reports to the rules under
However, section 223 of ERTA provided for a moratorium on the research and development allocation and apportionment regulations, reenactments of the moratorium, and statutory modifications to the regulations. The legislative history of such provisions indicate that Congress has been concerned with and has repeatedly reviewed the research and development expense provisions under In the 8 years since the first temporary moratorium on the 1977 regulation was enacted, Congress, the Treasury Department, and representatives of affected industries have intensely scrutinized the effects of the research and experimental allocation rules on research activities. [H. Rept. 101-247, at 1208 (1990).]
With regard to the requirement under the challenged
While section 223 of ERTA did provide that 100 percent of research and development expenses performed in the United States were to be allocated to U.S. source income where geographic sourcing was relevant, nothing in the legislative history of the moratorium and its extensions1991 U.S. Tax Ct. LEXIS 93">*149 indicates that Congress disapproved of the
Congressional review and approval of the challenged regulations is also implicit in congressional action related to the enactment of the intercompany pricing rules for foreign sales corporations (FSC's), which in large part replaced DISC's as part of the Deficit Reduction Act of 1984, Pub. L. 98-369, 98 Stat. 494. See
The Senate Finance Committee explanation states: In general, where the provisions1991 U.S. Tax Ct. LEXIS 93">*150 of the bill are identical or substantially similar to the DISC provisions under present law, the committee intends that rules comparable to the rules in regulations issued under those provisions will be applied to the FSC. [Deficit Reduction Act of 1984: Explanation of Provisions Approved by the Committee on March 21, 1984 (S. Rept. 98-169 (Vol. I), at 636 (1984).]
Among the relevant factors specified by the Supreme Court,
Due to the length of time the final 1977 regulations have been in effect, the close and repeated review of the challenged regulations by Congress and the Treasury, Congress' decision not to suspend the application1991 U.S. Tax Ct. LEXIS 93">*151 of the allocation and apportionment provisions with respect to a DISC, and petitioner's failure to produce any legislative history indicating congressional disapproval of the regulations or a lack of harmony with the origin and purpose of the DISC provisions, we reject petitioner's contention that
Petitioner argues that the allocation of research and development expenses attributable to cardiac pacemakers and insulin pumps to the gross income from export sales of prosthetic heart valves, 1991 U.S. Tax Ct. LEXIS 93">*152 as required by
The express language of
In support of its interpretation of Where a DISC is attempting to establish a market abroad or seeking to maintain a market abroad, for exports, the Secretary of the1991 U.S. Tax Ct. LEXIS 93">*153 Treasury may prescribe by regulations special rules governing the allocation of expenses incurred on the sale of the export property for purposes of determining the combined taxable income of the related person and the DISC. It is expected that in the appropriate cases the regulations will allow, for purposes of applying the pricing rule, the combined taxable income on the sale of export property to reflect a profit equal to that which the DISC and a related party would earn if they took into account only the marginal costs of producing the property. The production expenses not considered marginal costs in this case would, of course, be allocable to the production of the related party which is not sold to the DISC. [H. Rept. 92-533 (1971),
The congressional purpose behind the DISC provisions, argues petitioner, was to burden the gross receipts from the sale of export property with the least amount of
As we have already discussed and rejected petitioner's misinterpretation of the grouping provisions, we need not address petitioner's repetition of this argument. However, we note that the excerpt from the House and Senate Committee reports on which petitioner relies addresses the 97 T.C. 457">*489 marginal costing method of computing an intercompany transfer price. The marginal costing method is not at issue. 9
SIC Major Group | Nonmanufactured categories |
* * * | |
50, 51 | Wholesale trade (not applicable with respect to sales by the taxpayer of goods and services from any other of the taxpayer's product categories and |
The wholesale trade category is beneficial to taxpayers in allocating research and development expenses between a domestic corporation and its foreign sales subsidiary, as illustrated by
The domestic corporation also sells forklift trucks to a foreign sales subsidiary. The subsidiary's sales do not enter into the research and development expense allocation computations 97 T.C. 457">*490 because the regulations treat these sales as falling within SIC product categories 50 and 51, "Wholesale Trade." Further, the domestic corporation's intercompany sales to the subsidiary are treated as sales made within the United States even though title passes abroad.
The result is that the domestic corporation's research and development expenses are not apportionable to the foreign source income from the sales by the subsidiary.
Petitioner argues that
Petitioner quotes the testimony of John Connally, Secretary of the Treasury, before the Senate Finance Committee: The DISC is proposed in the form of a domestic corporation, incorporated under the laws of the United States. As will be explained, the same tax deferral benefit may be obtained in many cases under present law by using a * * * The DISC proposal is simply an1991 U.S. Tax Ct. LEXIS 93">*158 effort to cut through all this maze of complexity and provide, in forthright fashion, the opportunity for tax referral by use of a
Petitioner argues that the committee reports emphasize that the principal purpose of the DISC provisions was to grant the same advantageous tax deferral benefits to a DISC 97 T.C. 457">*491 that were available to a foreign sales subsidiary. The portion of the Senate Finance Committee report (which is almost identical to the House committee report) on which petitioner relies states: As indicated in the discussion of the reasons for the bill, the committee agrees with the House that it is important to provide tax incentives for U.S. firms to increase their exports. This is important not only because of its stimulative effect but also to remove a present disadvantage of U.S. companies engaged in export activities through domestic corporations. Presently, they are treated less favorably than those which manufacture abroad through the use of foreign subsidiary corporations. United1991 U.S. Tax Ct. LEXIS 93">*159 States corporations engaging in export activities are taxed currently on their foreign earnings at the full U.S. corporate income tax rate regardless of whether these earnings are kept abroad or repatriated. In contrast, U.S. corporations which produce and sell abroad through foreign subsidiaries generally can postpone payment of U.S. tax on these foreign earnings so long as they are kept abroad. Both to provide an inducement for increasing exports and as a means of removing discrimination against those who export through U.S. corporations, the House bill and the committee's bill provide a deferral of tax where corporations meeting certain conditions -- called Domestic International Sales Corporations -- are used. [S. Rept. 92-437 (1971),
Petitioner is in effect arguing that in enacting the DISC provisions Congress intended to create a domestic tax haven, with the only limitation on income tax deferral being the deemed distribution rules. While the legislative history of the DISC provisions establish that Congress intended to create the same
Congressional intent in this regard is established by
Congress' intent to place limits on combined taxable income for purposes of
Petitioner's argument is directed not at the regulations in issue, but at the transfer pricing methods provided by
Petitioner also argues that
The Secretary testified at hearings before the Senate Finance Committee that "The DISC proposal is simply an effort to cut through all this maze of complexity and provide, in forthright fashion, the opportunity for tax deferral by use of a
It would be a usurpation of the power of Congress, petitioner contends, to allow the Secretary to explain to Congress that the DISC proposal will place a DISC on equal footing with a foreign sales subsidiary, and then to promulgate regulations which deny a DISC, and provide a foreign sales subsidiary with, the opportunity to use the wholesale trade category in determining1991 U.S. Tax Ct. LEXIS 93">*163 the extent of its income tax deferral benefits.
However, the Secretary did not explain to Congress that the DISC proposal would place a DISC on "equal footing" with a foreign subsidiary; he merely states that both a DISC and a foreign sales subsidiary present an opportunity to defer taxes. The Secretary's statement is an accurate explanation of the purpose of the DISC provisions, and does not represent a usurpation of the power of Congress. The challenged regulations are in no way inconsistent with the Secretary's statement. We therefore reject petitioner's argument.
(ii) Apportionment of research and development -- sales method -- (A) Exclusive apportionment. Where an apportionment based upon geographic sources of income of a deduction for research and development is 97 T.C. 457">*494 necessary (after applying the exception in subdivision (i)(B) of this paragraph (e)(3)), an amount equal to -- (1) Fifty percent (50%), in the case of a taxable year beginning during 1977, (2) Forty percent (40%), in the case of a taxable year beginning during 1978, (3) Thirty percent (30%), in the case of a taxable year beginning during 1979, and thereafter, of such deduction for research and development shall be apportioned exclusively to the statutory grouping of gross income or the residual grouping of gross income, as the case may be, arising from the geographic source where the research and development activities which account for more than fifty percent (50%) of the amount of such deduction were performed. * * *
Petitioner argues that to the extent
Based on the analysis provided by example 23 of
The domestic corporation1991 U.S. Tax Ct. LEXIS 93">*166 incurs research and development expenses of $ 100,000, including $ 10,000 to meet 97 T.C. 457">*495 product safety standards, and $ 65,000 otherwise qualifying for the exclusive geographic apportionment method under For this purpose an exclusive apportionment is not available, since gross income from exports through a DISC and gross income from sales within the United States are both within the same geographic source, United States income * * * On the basis of X's facts and circumstances, $ 65,000 is apportioned exclusively to sources within the United States, namely gross income from exports through a DISC and gross income from sales within the United States.
Thus, example 23 is based on the premise that gross income from exports through a DISC and gross income from sales within the United States are both within the same geographic source, and therefore geographic sourcing is not an element of1991 U.S. Tax Ct. LEXIS 93">*167 the combined taxable income computation. Therefore, the exclusive geographic apportionment method is not applicable to the computation.
In arguing that
However, we note that the legislative history of section 223 of ERTA and its subsequent extensions,
1991 U.S. Tax Ct. LEXIS 93">*168 After concessions,
*. Brief amicus curiae was filed by
1. All statutory references are to the Internal Revenue Code as in effect for the years in issue, and all Rule references are to the Tax Court Rules of Practice and Procedure, except as otherwise noted.↩
2.
3. In its petition, petitioner alleges that respondent erred by failing to recognize the applicability of section 223 of the Economic Recovery Tax Act of 1981 (section 223 of ERTA), Pub. L. 97-34, 95 Stat. 172, 249, in computing combined taxable income. This position was not taken on the Forms 1120 and 1120 DISC returns filed by petitioner and International. However, the parties agree that the applicability of section 223 of ERTA is in issue.↩
4. See also H. Rept. 99-841 (Conf.) (1986),
The conference agreement does not reflect a judgment by the conferees that any provision of the existing regulation is necessarily correct or incorrect. It is anticipated that the Treasury Department will expeditiously pursue a permanent resolution of the allocation issue. The conferees do, however, consider it important that the Treasury Department reexamine its regulations in light of concerns expressed by the tax-writing committees of both Houses. * * *↩
5. The Senate Finance Committee report also states that the modifications provided for in sec. 1303 of its bill apply only for purposes of geographic sourcing, and do not apply to the computation of combined taxable income of an FSC or DISC. S. Rept. 99-313 (1986),
6.
7. The
X | tentative U.S. tax on | = | maximum foreign | |
worldwide taxable income | worldwide income | tax credit |
8. Congress did note that under the 1973 proposed regulations, a greater proportion of research and development expenses were allocable to foreign source income than under the final 1977 regulations at issue.↩
9.
10. In S. Rept. 92-437 (1971),
The committee agrees with the House that the deferral treatment made available to a DISC should be limited.↩